Venus Concept Inc. (NASDAQ:VERO) Short Interest Down 92.5% in November

Venus Concept Inc. (NASDAQ:VEROGet Free Report) saw a significant decline in short interest during the month of November. As of November 15th, there was short interest totalling 108,600 shares, a decline of 92.5% from the October 31st total of 1,450,000 shares. Based on an average daily trading volume, of 1,780,000 shares, the short-interest ratio is presently 0.1 days. Currently, 2.6% of the company’s shares are short sold.

Insiders Place Their Bets

In related news, major shareholder Michael Willingham Masters sold 94,553 shares of the firm’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $0.53, for a total transaction of $50,113.09. Following the completion of the sale, the insider now directly owns 17,059 shares of the company’s stock, valued at approximately $9,041.27. This trade represents a 84.72 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 57.98% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Venus Concept

An institutional investor recently raised its position in Venus Concept stock. Masters Capital Management LLC lifted its holdings in Venus Concept Inc. (NASDAQ:VEROFree Report) by 100.0% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 666,702 shares of the company’s stock after purchasing an additional 333,366 shares during the period. Masters Capital Management LLC owned approximately 10.49% of Venus Concept worth $522,000 at the end of the most recent reporting period. 87.41% of the stock is owned by institutional investors and hedge funds.

Venus Concept Stock Down 6.3 %

NASDAQ VERO traded down $0.02 on Friday, reaching $0.32. The stock had a trading volume of 97,832 shares, compared to its average volume of 1,091,955. Venus Concept has a 12-month low of $0.28 and a 12-month high of $2.22. The stock has a fifty day moving average price of $0.45 and a two-hundred day moving average price of $0.58. The company has a quick ratio of 1.18, a current ratio of 1.86 and a debt-to-equity ratio of 2.83.

About Venus Concept

(Get Free Report)

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.

Featured Articles

Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.